How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

被引：0
|
作者：
Kataoka, Naoya [1 ]
Imamura, Teruhiko [1 ]
机构：
[1] Univ Toyama, Dept Internal Med 2, Toyama, Japan
来源：
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2025年
关键词：
D O I：
10.1111/jce.16591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical comprehensive evaluation of direct oral anticoagulants for patients with atrial fibrillation in China
    Chi Zhang
    Zhi-Chun Gu
    Er-Li Ma
    Bing-Long Liu
    Mang-Mang Pan
    Jia Wang
    Xin Wang
    Bin Wu
    Hou-Wen Lin
    European Journal of Clinical Pharmacology, 2023, 79 : 1631 - 1639
  • [42] Safety of off-label dose reduction of non-vitamin K oral anticoagulants in patients with atrial fibrillation treated in routine care
    van den Dries, Carline
    van den Ham, Rianne
    Souverein, Patrick
    Pjouheshnia, Romin
    Geersing, Geert-Jan
    van Doorn, Sander
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 140 - 141
  • [43] Direct Oral Anticoagulants in Atrial Fibrillation
    Noll, Georg
    Noll, Sarah
    Huerlimann, David
    SEMINARS IN HEMATOLOGY, 2014, 51 (02) : 139 - 146
  • [44] Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
    Wu, Xiaojuan
    Hu, Linyan
    Liu, Jinjin
    Gu, Qiuping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [45] Common Drug Interactions of Direct Oral Anticoagulants and Their Impact on Clinical Outcomes in Atrial Fibrillation
    Sanborn, David
    Sugrue, Alan
    Amin, Mustapha
    Farwati, Medhat
    Mehta, Ramila
    Deshmukh, Abhishek
    Sridhar, Haarini
    Ahmed, Azza
    Madhavan, Malini
    CIRCULATION, 2019, 140
  • [46] Letter by de Vries et al Regarding Article "Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis"
    de Vries, Tim A. C.
    Hirsh, Jack
    Chan, Noel C.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (05): : 373 - 374
  • [47] Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients?
    S. Desmaele
    S. Steurbaut
    P. Cornu
    R. Brouns
    A. G. Dupont
    European Journal of Clinical Pharmacology, 2016, 72 : 1125 - 1134
  • [48] Clinical trials with direct oral anticoagulants for stroke prevention in atrial fibrillation: how representative are they for real life patients?
    Desmaele, S.
    Steurbaut, S.
    Cornu, P.
    Brouns, R.
    Dupont, A. G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (09) : 1125 - 1134
  • [49] Current Real-World Status of Off-Label Under- and Over-Dose of Direct Oral Anticoagulants After Atrial Fibrillation Ablation
    Kino, Tabito
    Nogami, Akihiko
    Soejima, Kyoko
    Uno, Kikuya
    Kumagai, Koichiro
    Kurita, Takashi
    Fukuzawa, Masayuki
    Takita, Atsushi
    Ishizu, Tomoko
    Aonuma, Kazutaka
    RYOUMA Registry Investigators
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
  • [50] Off-label Use for Direct Oral Anticoagulants: Valvular Atrial Fibrillation, Heart Failure, Left Ventricular Thrombus, Superficial Vein Thrombosis, Pulmonary Hypertension-a Systematic Review
    Brokmeier, Hannah
    Kido, Kazuhiko
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (08) : 995 - 1009
12345